RecruitingNot ApplicableNCT06005103

A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression

Active Versus Sham Transcranial Pulsed Electromagnetic Field Headband Treatment for Major Depression: a Study Protocol for a Double-blinded Randomized Trial


Sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital

Enrollment

117 participants

Start Date

Jun 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

An 8-week, two-armed, randomized-controlled trial that examines the antidepressant effect of treatment with transcranial pulsed electromagnetic fields (T-PEMF) in patients diagnosed with moderate to severe depression using using a new device, the MoodHeadBand (MHB). The participants will use an active or placebo MHB for 30 minutes daily for 8 weeks. Additionally, the following research questions will be answered: 1\. If there is a positive effect on the patients' emotional and non-emotional cognition after 8 weeks of active treatment compared to the sham group and if possible early changes in the emotional cognition can predict the treatment response after 8 weeks of treatment. 1\. If the T-PEMF treatment provides improvement in restorative sleep after 8 weeks of treatment


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Meeting the diagnostic criteria for moderate to severe depressive episode without psychotic symptoms according to the International Classification of Diseases and Related Health Problems 10th Revision (ICD-10)(The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993).
  • Female participants: Females in the fertile age must deliver a negative pregnancy test, or previously have been sterilized.
  • Female fertile participants: They must use safe contraceptive methods to be included in the study, and during the whole study.
  • Has given written, informed consent to the trial.

Exclusion Criteria9

  • Inability to speak or understand the Danish language.
  • A current high risk of suicide (a score of 2 or more on the HAM-D-17 item 3).
  • A co-morbid substance dependence.
  • Bipolar affective disorder.
  • Psychotic illness.
  • Dementia.
  • Other diagnoses of organic brain disease.
  • The participant has any kind of implant, e.g. pacemakers or cochlear implants.
  • Female participants: Pregnancy

Interventions

DEVICETreatment with MoodHeadBand (T-PEMF treatment)

The patients will receive treatment with T-PEMF using a headband containing 20 coils placed symmetrically around the head of the patient. The device delivers 55 Hz magnetic field. Duration of treatment is 30 minutes once a day for 8 weeks.

DEVICEInactive treatment with MoodHeadBand (Placebo)

Patients will use an identical device, which does not deliver T-PEMF treatment. The patients will use the headband as the active group for 30 minutes, once a day, for 8 weeks.


Locations(1)

Psychiatric Center Copenhagen

Frederiksberg, Capital Region, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06005103


Related Trials